Monash University
Greg Moseley
Email: greg.moseley@monash.edu
T: +61 3 9905 1036
F: +61 3 9902 9222
Web: https://research.monash.edu/en/persons/gregory-moseley
Twitter: @gregwmoseley, @moseley_lab
Facebook: www.facebook.com/Moseley-Lab-222691648443326
Associate Professor Vijaykrishna Dhanasekaran (Vijay)
BSc, MSc, MPhil (University of Madras) Microbiology, PhD (University of Hong Kong) Ecology and Evolution and Postdoctoral training (University of Hong Kong). Head, Laboratory of Virus Evolution and Infectious Disease dynamics. Biomedicine Discovery Fellow. Adjunct Associate Professor Duke-NUS Medical School, Singapore, and visiting consultant, WHO Influenza Collaborating Center for Reference and Research on Influenza, Melbourne.
Email: vijay.dhanasekaran@monash.edu
Phone: +613 9905 5415
Web: https://research.monash.edu/en/persons/vijay-dhanasekaran
Twitter Handle: @vijay_lab
Viral disease progression is critically dependent on the formation of specific interaction networks between viral proteins and host cell factors, which enable viral subversion of important processes such as antiviral immunity and cell survival.
Research in our laboratory seeks to elucidate these interactions at the molecular level, particularly interactions involved in immune evasion, and to understand their functions in diseases caused by highly lethal human viruses, including rhabdoviruses (e.g. rabies virus, Australian bat lyssavirus), paramyxoviruses (e.g. Nipah, Hendra, measles) and filoviruses (e.g. Ebola), as well as a number of agriculturally significant and potentially zoonotic animal viruses.
The overarching aim of the research is to identify novel targets and strategies for the development of new vaccines and therapeutics for currently incurable viral diseases.
Department of Microbiology, Biomedicine Discovery Institute
Monash University
19 Innovation Walk (Bldg 76)
Clayton Campus, Victoria 3800
Australia
The overarching goal of my laboratory is studying the factors that shape the emergence, evolution, and incidence of rapidly evolving viral pathogens such as influenza with a focus on improving control and therapeutic strategies. We conduct disease surveillance in animals and humans, employ molecular virology, genomics and experimental evolution experiments, and use computational methods in evolutionary biology and epidemiology in our research. Our current research interests include the development of universal vaccination approaches against seasonal and pandemic influenza viruses by better understanding the impact of population level immunity on virus evolution.